Janney Upgrades Amicus Therapeutics (FOLD) to Buy

Janney Montgomery Scott upgraded Amicus Therapeutics (NASDAQ: FOLD) from Neutral to Buy with a price target of $5.00 (from $2.50).

For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.

Shares of Amicus Therapeutics closed at $3.34 yesterday.

You May Also Be Interested In

• Cantor Fitzgerald Upgrades Omeros Corp. (OMER) to Overweight, 'We May Have Underestimated Yartemlea'
• Chord Energy Corp (CHRD) PT Lowered to $184 at UBS on Model Updates Following Non-Core Marcellus Sale
• Astra International Tbk PT (ASII:IJ) (PTAIY) PT Lowered to IDR6,450 at JPMorgan